NCT06745063: Arterial Destiffening Effects of SGLT2 Inhibition in Veterans With Obesity
- State
- Under way
- Phase
- Phase 2
- People
- 50 planned
- Started
- 30 May 2025
- Primary completion
- 31 Dec 2028
- Arms
- Empagliflozin
- Results
- None posted
- 20 Dec 2024: Trial registered
- 30 May 2025: Trial started